These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1442831)

  • 1. Visual compatibility of diltiazem with commonly used injectable drugs during simulated Y-site administration.
    Zanetti LA
    Am J Hosp Pharm; 1992 Aug; 49(8):1911. PubMed ID: 1442831
    [No Abstract]   [Full Text] [Related]  

  • 2. Visual compatibility of diltiazem injection with various diluents and medications during simulated Y-site injection.
    Gayed AA; Keshary PR; Hinkle RL
    Am J Health Syst Pharm; 1995 Mar; 52(5):516-20. PubMed ID: 7606558
    [No Abstract]   [Full Text] [Related]  

  • 3. Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
    Min DI; Brown T; Hwang GC
    Am J Hosp Pharm; 1992 Dec; 49(12):2964-6. PubMed ID: 1282779
    [No Abstract]   [Full Text] [Related]  

  • 4. Visual compatibility of fluconazole with commonly used injectable drugs during simulated Y-site administration.
    Lor E; Sheybani T; Takagi J
    Am J Hosp Pharm; 1991 Apr; 48(4):744-6. PubMed ID: 2042678
    [No Abstract]   [Full Text] [Related]  

  • 5. Visual compatibility of haloperidol lactate with 0.9% sodium chloride injection or injectable critical-care drugs during simulated Y-site injection.
    Outman WR; Monolakis J
    Am J Hosp Pharm; 1991 Jul; 48(7):1539-41. PubMed ID: 1882889
    [No Abstract]   [Full Text] [Related]  

  • 6. Visual compatibility of morphine sulfate and meperidine hydrochloride with other injectable drugs during simulated Y-site injection.
    Pugh CB; Pabis DJ; Rodriguez C
    Am J Hosp Pharm; 1991 Jan; 48(1):123-5. PubMed ID: 2000871
    [No Abstract]   [Full Text] [Related]  

  • 7. Visual compatibility of zidovudine with other injectable drugs during simulated Y-site administration.
    Bashaw ED; Amantea MA; Minor JR; Gallelli JF
    Am J Hosp Pharm; 1988 Dec; 45(12):2532-3. PubMed ID: 3228107
    [No Abstract]   [Full Text] [Related]  

  • 8. Visual compatibility of foscarnet with other injectable drugs during simulated Y-site administration.
    Baltz JK; Kennedy P; Minor JR; Gallelli J
    Am J Hosp Pharm; 1990 Sep; 47(9):2075-7. PubMed ID: 2145761
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual compatibility of neuromuscular blocking agents with various injectable drugs during simulated Y-site injection.
    Savitsky ME
    Am J Hosp Pharm; 1990 Apr; 47(4):820-1. PubMed ID: 1969713
    [No Abstract]   [Full Text] [Related]  

  • 10. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual compatibility of labetalol hydrochloride injection with various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Jun; 45(6):1357-8. PubMed ID: 3414706
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
    Colucci RD; Cobuzzi LE; Halpern NA
    Am J Hosp Pharm; 1988 Mar; 45(3):630-2. PubMed ID: 2897164
    [No Abstract]   [Full Text] [Related]  

  • 14. Visual compatibility of ganciclovir sodium and total parenteral nutrient solution during simulated Y-site injection.
    Outman WR; Mitrano FP; Baptista RJ
    Am J Hosp Pharm; 1991 Jul; 48(7):1538-9. PubMed ID: 1909095
    [No Abstract]   [Full Text] [Related]  

  • 15. Visual compatibility of acyclovir sodium with commonly used intravenous drugs simulated Y-site injection.
    Forman JK; Lachs JR; Souney PF
    Am J Hosp Pharm; 1987 Jun; 44(6):1408-9. PubMed ID: 3618621
    [No Abstract]   [Full Text] [Related]  

  • 16. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual compatibility of haloperidol lactate with injectable solutions.
    Fraser GL; Riker RR
    Am J Hosp Pharm; 1994 Apr; 51(7):905-6. PubMed ID: 8017441
    [No Abstract]   [Full Text] [Related]  

  • 18. Visual compatibility of famotidine with commonly used critical-care medications during simulated Y-site injection.
    Jay GT; Fanikos J; Souney PF
    Am J Hosp Pharm; 1988 Jul; 45(7):1556-7. PubMed ID: 3414721
    [No Abstract]   [Full Text] [Related]  

  • 19. Visual compatibility of cimetidine hydrochloride with common preoperative injectable medications.
    Souney PF; Solomon MA; Stancher D
    Am J Hosp Pharm; 1984 Sep; 41(9):1840-1. PubMed ID: 6496520
    [No Abstract]   [Full Text] [Related]  

  • 20. Visual compatibility of premixed theophylline or heparin with selected drugs for i.v. administration.
    Kershaw BP; Monnier HL; Mason JH
    Am J Hosp Pharm; 1993 Jul; 50(7):1360, 1362-3. PubMed ID: 8362868
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.